PPCB CIK: 1517681

Propanc Biopharma, Inc.

  • Australia
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
–
FY26:
0
(positive)
Change from FY22 to FY26
millions USD
FY22:
−1.99
FY23:
−1.78
FY24:
−1.54
FY25:
−57.3
FY26:
−18.2
(positive)
Change from FY22 to FY25
millions USD
FY22:
−1.98
FY23:
−1.75
FY24:
−1.51
FY25:
−57.3
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−2.71
FY23:
−2.79
FY24:
−1.95
FY25:
−58.9
FY26:
−18.9
(positive)
Change from FY22 to FY26
millions USD
FY22:
−2.66
FY23:
−2.66
FY24:
−1.82
FY25:
−58.9
FY26:
−18.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data